{
    "nctId": "NCT04387630",
    "briefTitle": "Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.",
    "officialTitle": "Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Clinical Response rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically proven breast carcinoma.\n* American Society of Anesthesiology (ASA) score I-II.\n* Candidate for neoadjuvant chemotherapy as per hospital's protocol.\n* Clinically measurable tumor.\n* No evidence of distant metastasis.\n* Normal renal and liver functions.\n* Non-diabetics.\n\nExclusion Criteria:\n\n* Pregnant or lactating women.\n* Metastatic breast cancer patients.\n* Patients with hepatic impairment.\n* Patients with renal impairment.\n* Diabetics.\n* Patients unwilling to participate or withdrawing from the trial.\n* Psychological/ mental impairment.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}